Cd45 inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C552S292000

Reexamination Certificate

active

06939896

ABSTRACT:
Substituted naphthalenediones in accord with structural diagram (I): compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In compounds of the invention, wherein: Q1at each occurrence is independently selected from hydrogen, hydroxy, halogen, C(O)O(C1-C3) alkyl and C(O)phenyl, and Q2is selected from hydrogen, halogen, O—(C1-C3)alkyl, O—(C1-C3)alkenyl, phenyl, indolyl and naphthyl, where phenyl may be mono- or di-substituted with NO2or halogen, and indolyl may be substituted with (C1-C3)alkyl or phenyl

REFERENCES:
patent: 5508310 (1996-04-01), Rhodes
patent: 5684035 (1997-11-01), Kapadia
patent: 5866569 (1999-02-01), Mjalli et al.
patent: 5883270 (1999-03-01), Frydman et al.
patent: WO97/31611 (1997-09-01), None
Perumal et al., “Oxidation of halophenols and highly substituted phenols with lead(IV) acetate.” Synthesis, vol. 1980 (11), pp. 943-945, Nov. 1980.
Takuwa et al., “The addition of alcohol to 1,2-naphthoquinone promoted by metal ions. A facile synthesis of 4-alkoxy-1,2-naphthoquinones.” Bull. of hte Chem. Soc. of Japan, vol. 59, pp. 2959-2961, 1986.
Itahara, “Oxidative coupling of quinones and aromatic compounds by palladium (II) acetate.” J. Org. Chem., vol. 50, pp. 5546-5550, 1985.
Henrion et al., “Condensation indole/1,2-naphthoquinone. Recherche des conditions optimales dans la preparation d'une nouvelle serie de 4-(3-indolyl)-1,2-naphtoquinones.” Bull. des societes chimisques belges, vol. 105(7), pp. 415-418, 1996.
Grinev et al., “Synthesis of bis(diethylaminoethyl)-1,2-dimethyl-8-oxoindeno-[2,1-b]pyrrole-3,5-dicarboxylate.” Chem. Heterocyclic Compounds (English translation), vol. 19, pp. 876-879, 1983.
P. Perumal et al.: “Oxidation of Halophenols and Highly Substituted Phenols with Lead (IV) Acetate” SYNTHESIS, vol. 1980, No. 11, Nov. 1980, pp. 943-945, XP001026188 p. 944, compounds 1a and 2a.
A. Takuma et al.: “The Addition of Alcohol to 1,2-Naphthoquinone Promoted by Metal Ions. A Facile Synthesis of 4-Alkoxyl-1, 2-Naphthoquinones” Bulletin of the Chemical Society of Japan, vo. 59, Sep. 1986, pp. 2959-2961, XP002142395 p. 2959, compounds 2a-2f.
T. Itahara: “Oxidative Coupling of Quinones and Aromatic Compounds by Palladium (II) Acetate.” Journal of Organic Chemistry, vol. 50, 1985, pp. 5546-5550, XP002044654, p. 4455, Table I, compounds 8a and 8c.
J.C. Henrion et al.: “Condensation Indole-1,2-naphthoquinone. Recherche des Conditions Optimales dans la Preparation d'une Nouvelle Serie de 4—(3-Indolyl)-1, 2-naphthoquinones. ” Bulletin Des Societes Chimiques Belges, vol. 105, No. 7, 1996, pp. 415-418, XP001026771 p. 416, compounds 3a-3e.
A.N. Grinev et al.: “Synthesis of bis(diethylaminoethyl) -1,2-dimethyl-8-oxoindeno [2,1-b] pyrroloe-3,5-dicarboxylate.” Chemistry of Heteroxyxlic Compounds (English Translation), vol. 19, 1983, pp. 876-879, XP001026781 p. 877, compound No. 1.
R.A. Urbanek et al. : “Potent Reversible Inhibitors of the Protein Tyrosine Phosphatase CD45” Journal of Medicinal Chemistry, vol. 44, 2001, pp. 1777-1793, XP001014517 tables 1-3.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cd45 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cd45 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd45 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3417492

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.